CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 24 Mar 2023

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Azithromycin (Primary) ; Clarithromycin; Ethambutol; Rifampicin
Indications Mycobacterium avium complex infections
Focus Therapeutic Use
Acronyms CLAZI

Most Recent Events

21 Mar 2023 Planned End Date changed from 1 Feb 2023 to 1 Feb 2025.
21 Mar 2023 Planned primary completion date changed from 1 Feb 2023 to 1 Feb 2025.
17 Sep 2018 Planned End Date changed from 20 Sep 2022 to 1 Feb 2023.

Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

IP authentication when working within your organization’s network.
Login with username/password or try access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days.
Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Contact your organization’s admin about adding this content to your AdisInsight subscription
Buy a PDF version of the profile.
Request a free trial

Welcome to AdisInsight